"Yale Engage Cancer Series," Presented by Corporate Strategy and Engagement Office, OCR, and Yale Cancer Center
In conjunction with Yale Cancer Center and the Office of Cooperative Research, the Corporate Strategy and Engagement office presents Yale Engage, an interactive webinar series promoting impactful collaboration between academic experts and industry executives. This is designed for a broad corporate audience, but particularly of interest for executives and leaders in Research & Development, Business Development, Strategy, and Innovation in sectors such as Biotechnology, Pharmaceutical, Healthcare, Technology, and Venture Capital.
These sessions will feature corporate speakers with a panel of renowned Yale physicians and scientists addressing critical challenges.
With real-time dialogue and strategic introductions, we will pinpoint issues and research goals to advance shared, scalable solutions. In the fight against cancer, Yale Cancer Center is at the forefront of understanding the fundamental mechanisms of cancer biology and in developing effective cancer treatment therapies. The Cancer Center harnesses the resources of the Yale School of Medicine and Smilow Cancer Hospital at Yale New Haven to advance cancer research, prevention, and patient care, as well as community outreach and education.
- Oct 202021Wednesday11:00 AM12:30 PMMarcus Bosenberg, MD, PhD - Grace Chen, PhD - Roy S. Herbst, MD, PhD - Akiko Iwasaki, PhD - Aaron Ring, MD, PhD
- Nov 20205Thursday11:00 AM12:30 PMRanjit S. Bindra, MD, PhD - Sidi Chen, PhD - Craig Crews, PhD - Faye Rogers, PhD
Novel Therapeutics & Delivery Systems
- Dec 20209Wednesday1:00 PM2:30 PMMegan C. King, PhD - Mark A Lemmon, PhD, FRS - Katerina Politi, PhD - Kurt Schalper, MD, PhD - Qin Yan, PhD
Defining Mechanisms and Biomarkers of Sensitivity & Resistance To Anti-Cancer Treatments